Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)

Hyundai Bioscience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	17,082	22,338	3,657	1,812	2,732	9,189
Short-Term Investments	24,753	17,739	-	10,000	16,000	13,010
Cash & Short-Term Investments	41,835	40,077	3,657	11,812	18,732	22,199
Cash Growth	17.66%	996.00%	-69.04%	-36.94%	-15.62%	15.53%
Accounts Receivable	618.51	2,325	247.21	446.21	1,277	7,628
Other Receivables	56.51	96.01	85.09	19.54	50.97	55.15
Receivables	675.02	2,421	332.3	465.75	1,671	8,825
Inventory	789.2	1,137	1,076	2,588	2,946	3,350
Prepaid Expenses	323.46	138.25	381.52	204.45	568.66	337.92
Other Current Assets	178.37	217.44	1,364	92.36	93.33	138.65
Total Current Assets	43,801	43,990	6,810	15,163	24,012	34,851
Property, Plant & Equipment	4,538	3,652	3,583	2,904	6,376	6,073
Long-Term Investments	29,766	29,720	22,732	1,593	1,469	4,930
Other Intangible Assets	52,170	52,170	33,170	31,170	33,175	33,664
Other Long-Term Assets	442.82	506.6	498.05	914.36	1,268	929.34
Total Assets	131,305	130,739	67,705	52,792	67,327	80,528

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	498.04	498.72	555.33	430.52	686.72	191.61
Accrued Expenses	178.52	144.72	137.19	141.71	141.35	123.66
Short-Term Debt	15,060	17,264	25,832	5,400	5,900	14,014
Current Portion of Long-Term Debt	-	-	-	-	111.08	833.32
Current Portion of Leases	383.51	448.86	440.49	114.1	196.17	354.1
Other Current Liabilities	2,406	1,164	521.41	860.43	1,957	1,744
Total Current Liabilities	18,527	19,521	27,487	6,947	8,992	17,261
Long-Term Debt	6,262	-	-	-	-	111.08
Long-Term Leases	348.97	70.44	320.53	32.43	41.7	174.69
Pension & Post-Retirement Benefits	63.04	-	-	-	-	57.13
Long-Term Deferred Tax Liabilities	-	-	-	-	-	1,296
Other Long-Term Liabilities	2,799	421.13	459.04	541.56	57.23	57.23
Total Liabilities	27,999	20,012	28,266	7,521	9,091	18,957

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	48,253	48,020	19,911	19,905	19,841	19,330
Additional Paid-In Capital	101,710	96,832	39,806	38,827	145,476	133,406
Retained Earnings	-58,561	-41,851	-19,741	-12,812	-106,288	-90,481
Treasury Stock	-4.04	-4.04	-4.04	-4.04	-4.04	-4.04
Comprehensive Income & Other	11,909	7,729	-532.99	-645.72	-789.52	-680.57
Shareholders' Equity	103,306	110,726	39,438	45,271	58,235	61,571
Total Liabilities & Equity	131,305	130,739	67,705	52,792	67,327	80,528

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	22,055	17,784	26,593	5,547	6,249	15,488
Net Cash (Debt)	19,781	22,293	-22,937	6,265	12,483	6,712
Net Cash Growth	-38.54%	-	-	-49.81%	86.00%	-
Net Cash Per Share	205.82	237.11	-288.02	78.76	158.55	90.90
Filing Date Shares Outstanding	96.14	96.04	79.64	79.62	79.36	77.31
Total Common Shares Outstanding	96.14	96.04	79.64	79.62	79.36	77.31
Working Capital	25,274	24,469	-20,677	8,216	15,020	17,590
Book Value Per Share	1074.53	1152.93	495.22	568.62	733.80	796.36
Tangible Book Value	51,136	58,556	6,269	14,101	25,061	27,906
Tangible Book Value Per Share	531.89	609.72	78.71	177.11	315.78	360.94
Land	1,100	1,100	1,100	1,100	1,100	1,100
Buildings	3,834	3,834	3,834	3,834	5,190	5,190
Machinery	10,495	10,435	10,435	10,435	11,644	13,822
Construction In Progress	-	26.55	114.29	16	773.4	225

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error